Live Breaking News & Updates on Theralink Technologies Inc|Page 5

Stay updated with breaking news from Theralink technologies inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Theralink To Be Bought By IMAC Holdings In Stock-for-stock Reverse Merger

Healthcare companies, Theralink Technologies, Inc. (THER) and IMAC Holdings, Inc. (BACK) announced on Tuesday that they have inked a deal through which Theralink will merge with a newly-formed wholly-owned unit of IMAC in a stock-for-stock reverse merger transaction. ....

Mick Ruxin , Holdings Inc , Theralink Technologies Inc , Theralink Technologies ,

Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

/PRNewswire/ Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein and protein. ....

United States , Mick Ruxin , Emanuel Petricoin , Justin Balko , Theralink Technologies Inc , Prnewswire Theralink Technologies Inc , Vanderbilt University Medical Center , Vanderbilt University , Science Advisory Board , Associate Professor , Theralink Assay , Patent Details , Theralink Technologies , Reverse Phase Protein Array ,

Theralink® Technologies Begins Receiving Payments from Third Party Payors for its Advanced Breast Cancer Assay, Achieving Key Milestone

/PRNewswire/ Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay for. ....

United States , Mick Ruxin , Theralink Technologies Inc , Reverse Phase Protein Array , Theralink Technologies ,

Theralink's Exclusive Licensed RPPA Technology for Commercial Laboratory Testing to Assist the White House Cancer Moonshot Initiative

/PRNewswire/ Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel quantitative protein and. ....

United States , White House , District Of Columbia , Mason Center , George Mason Universityannounced , Mick Ruxin , Theralink Technologies Inc , George Mason University , Cancer Moonshot Initiative , White House Cancer Moonshot Initiative , George Mason University College Of Science , University Professor , White House Cancer Moonshot , Chief Executive Officer , Reverse Phase Protein Assay , George Mason , Applied Proteomics , Molecular Medicine , George Mason University College , Scientific Advisory Board Where , Theralink Technologies , Reverse Phase Protein Array ,

Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say

By Nancy Lapid (Reuters) - The rush to use AstraZeneca and Daiichi-Sankyo's drug Enhertu to treat certain types of breast cancer has far outpaced doct. ....

San Antonio , United States , David Rimm , Nancy Lapid , Caroline Humer , Yale University , Theralink Technologies Inc , National Cancer Institute , Drug Administration , National Cancer , San Antonio Breast Cancer , Bill Berkrot ,